1. Katzman R, Saitoh T. Advances in Alzheimer’s disease. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1991;5(3):278-286. PMID:
2001787.
2. Ittner LM, Gotz J. Amyloid-beta and tau--a toxic pas de deux in Alzheimer’s disease. Nature reviews Neuroscience 2011;12(2):65-72. PMID:
21193853.
3. Tschampa HJ, Schulz-Schaeffer W, Wiltfang J, Poser S, Otto M, Neumann M, Kretzschmar HA. Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies. Neurology 2001;56(4):576PMID:
11222819.
4. Iqbal K, Grundke-Iqbal I, Smith AJ, George L, Tung YC, Zaidi T. Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America 1989;86(14):5646-5650. PMID:
2501795.
5. Lee VM, Balin BJ, Otvos L Jr, Trojanowski JQ. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science (New York, NY) 1991;251(4994):675-678.
6. Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annual review of neuroscience 2001;24:1121-1159.
7. Harris H, Rubinsztein DC. Control of autophagy as a therapy for neurodegenerative disease. Nature reviews Neurology 2012;8(2):108-117. PMID:
22187000.
8. Oddo S. The role of mTOR signaling in Alzheimer disease. Frontiers in bioscience (Scholar edition) 2012;4:941-952. PMID:
22202101.
9. Tang Z, Bereczki E, Zhang H, Wang S, Li C, Ji X, Branca RM, Lehtio J, Guan Z, Filipcik P, Xu S, Winblad B, Pei JJ. Mammalian Target of Rapamycin (mTor) Mediates Tau Protein Dyshomeostasis: IMPLICATION FOR ALZHEIMER DISEASE. The Journal of biological chemistry 2013;288(22):15556-15570. PMID:
23585566.
10. Bhaskar PT, Hay N. The two TORCs and Akt. Developmental cell 2007;12(4):487-502. PMID:
17419990.
11. Dazert E, Hall MN. mTOR signaling in disease. Current opinion in cell biology 2011;23(6):744-755. PMID:
21963299.
12. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nature reviews Molecular cell biology 2011;12(1):21-35. PMID:
21157483.
13. Burnett PE, Barrow RK, Cohen NA, Snyder SH, Sabatini DM. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proceedings of the National Academy of Sciences of the United States of America 1998;95(4):1432-1437. PMID:
9465032.
14. Ferraro E, Cecconi F. Autophagic and apoptotic response to stress signals in mammalian cells. Archives of biochemistry and biophysics 2007;462(2):210-219. PMID:
17374522.
15. Rami A. Review: autophagy in neurodegeneration: firefighter and/or incendiarist? Neuropathology and applied neurobiology 2009;35(5):449-461. PMID:
19555462.
16. Levine B, Yuan J. Autophagy in cell death: an innocent convict? The Journal of clinical investigation 2005;115(10):2679-2688. PMID:
16200202.
17. An WL, Cowburn RF, Li L, Braak H, Alafuzoff I, Iqbal K, Iqbal IG, Winblad B, Pei JJ. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer’s disease. The American journal of pathology 2003;163(2):591-607. PMID:
12875979.
18. Griffin RJ, Moloney A, Kelliher M, Johnston JA, Ravid R, Dockery P, O’Connor R, O’Neill C. Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer’s disease pathology. Journal of neurochemistry 2005;93(1):105-117. PMID:
15773910.
19. Pei JJ, Bjorkdahl C, Zhang H, Zhou X, Winblad B. p70 S6 kinase and tau in Alzheimer’s disease. Journal of Alzheimer’s disease : JAD 2008;14(4):385-392. PMID:
18688088.
20. Pei JJ, Hugon J. mTOR-dependent signalling in Alzheimer’s disease. Journal of cellular and molecular medicine 2008;12(6B):2525-2532. PMID:
19210753.
21. Meske V, Albert F, Ohm TG. Coupling of mammalian target of rapamycin with phosphoinositide 3-kinase signaling pathway regulates protein phosphatase 2A- and glycogen synthase kinase-3-dependent phosphorylation of Tau. The Journal of biological chemistry 2008;283(1):100-109. PMID:
17971449.
22. Caccamo A, Maldonado MA, Majumder S, Medina DX, Holbein W, Magri A, Oddo S. Naturally secreted amyloid-beta increases mammalian target of rapamycin (mTOR) activity via a PRAS40-mediated mechanism. The Journal of biological chemistry 2011;286(11):8924-8932. PMID:
21266573.
24. Puighermanal E, Marsicano G, Busquets-Garcia A, Lutz B, Maldonado R, Ozaita A. Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nature neuroscience 2009;12(9):1152-1158. PMID:
19648913.
25. Russo-Neustadt A, Ha T, Ramirez R, Kesslak JP. Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model. Behavioural brain research 2001;120(1):87-95. PMID:
11173088.
26. Swain RA, Harris AB, Wiener EC, Dutka MV, Morris HD, Theien BE, Konda S, Engberg K, Lauterbur PC, Greenough WT. Prolonged exercise induces angiogenesis and increases cerebral blood volume in primary motor cortex of the rat. Neuroscience 2003;117(4):1037-1046. PMID:
12654355.
27. Trejo JL, Carro E, Torres-Aleman I. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. The Journal of neuroscience : the official journal of the Society for Neuroscience 2001;21(5):1628-1634. PMID:
11222653.
28. Bayod S, Del Valle J, Canudas AM, Lalanza JF, Sanchez-Roige S, Camins A, Escorihuela RM, Pallas M. Long-term treadmill exercise induces neuroprotective molecular changes in rat brain. Journal of applied physiology (Bethesda, Md : 1985) 2011;111(5):1380-1390.
29. Cho JY, Um HS, Kang EB, Cho IH, Kim CH, Cho JS, Hwang DY. The combination of exercise training and alpha-lipoic acid treatment has therapeutic effects on the pathogenic phenotypes of Alzheimer’s disease in NSE/APPsw-transgenic mice. International journal of molecular medicine 2010;25(3):337-346. PMID:
20127037.
30. Um HS, Kang EB, Koo JH, Kim HT, Jin L, Kim EJ, Yang CH, An GY, Cho IH, Cho JY. Treadmill exercise represses neuronal cell death in an aged transgenic mouse model of Alzheimer’s disease. Neuroscience research 2011;69(2):161-173. PMID:
20969897.
31. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F, Libra M, Basecke J, Evangelisti C, Martelli AM, Franklin RA. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochimica et biophysica acta 2007;1773(8):1263-1284. PMID:
17126425.
32. Scheid MP, Woodgett JR. PKB/AKT: functional insights from genetic models. Nature reviews Molecular cell biology 2001;2(10):760-768. PMID:
11584303.
33. Martinez A, Castro A, Dorronsoro I, Alonso M. Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation. Medicinal research reviews 2002;22(4):373-384. PMID:
12111750.
34. Villamil-Ortiz JG, Cardona-Gomez GP. Comparative analysis of autophagy and tauopathy related markers in cerebral ischemia and Alzheimer’s disease animal models. Frontiers in aging neuroscience 2015;7:84PMID:
26042033.
35. Caron E, Ghosh S, Matsuoka Y, Ashton-Beaucage D, Therrien M, Lemieux S, Perreault C, Roux PP, Kitano H. A comprehensive map of the mTOR signaling network. Molecular systems biology 2010;6:453PMID:
21179025.
38. Cao Y, Klionsky DJ. Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell research 2007;17(10):839-849. PMID:
17893711.
39. Fujita N, Itoh T, Omori H, Fukuda M, Noda T, Yoshimori T. The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Molecular biology of the cell 2008;19(5):2092-2100. PMID:
18321988.
40. Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger PA, Small S, Spencer B, Rockenstein E, Levine B, Wyss-Coray T. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. The Journal of clinical investigation 2008;118(6):2190-2199. PMID:
18497889.
41. Rohn TT, Wirawan E, Brown RJ, Harris JR, Masliah E, Vandenabeele P. Depletion of Beclin-1 due to proteolytic cleavage by caspases in the Alzheimer’s disease brain. Neurobiology of disease 2011;43(1):68-78. PMID:
21081164.
42. Zatloukal K, Stumptner C, Fuchsbichler A, Heid H, Schnoelzer M, Kenner L, Kleinert R, Prinz M, Aguzzi A, Denk H. p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. The American journal of pathology 2002;160(1):255-263. PMID:
11786419.
44. Zheng YT, Shahnazari S, Brech A, Lamark T, Johansen T, Brumell JH. The adaptor protein p62/SQSTM1 targets invading bacteria to the autophagy pathway. Journal of immunology (Baltimore, Md : 1950) 2009;183(9):5909-5916.
45. Ohia-Nwoko O, Montazari S, Lau YS, Eriksen JL. Long-term treadmill exercise attenuates tau pathology in P301S tau transgenic mice. Molecular neurodegeneration 2014;9:54PMID:
25432085.
46. He C, Sumpter R Jr, Levine B. Exercise induces autophagy in peripheral tissues and in the brain. Autophagy 2012;8(10):1548-1551. PMID:
22892563.
47. Marques-Aleixo I, Santos-Alves E, Balca MM, Rizo-Roca D, Moreira PI, Oliveira PJ, Magalhaes J, Ascensao A. Physical exercise improves brain cortex and cerebellum mitochondrial bioenergetics and alters apoptotic, dynamic and auto(mito)phagy markers. Neuroscience 2015;301:480-495. PMID:
26116519.
48. Grimes CA, Jope RS. The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Progress in neurobiology 2001;65(4):391-426. PMID:
11527574.
49. Wolf DM, Vazirani VV, Arkin AP. Diversity in times of adversity: probabilistic strategies in microbial survival games. Journal of theoretical biology 2005;234(2):227-253. PMID:
15757681.
50. Leem YH, Lim HJ, Shim SB, Cho JY, Kim BS, Han PL. Repression of tau hyperphosphorylation by chronic endurance exercise in aged transgenic mouse model of tauopathies. Journal of neuroscience research 2009;87(11):2561-2570. PMID:
19360903.
51. Mirochnic S, Wolf S, Staufenbiel M, Kempermann G. Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease. Hippocampus 2009;19(10):1008-1018. PMID:
19219917.
52. Wolf SA, Kronenberg G, Lehmann K, Blankenship A, Overall R, Staufenbiel M, Kempermann G. Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer’s disease. Biological psychiatry 2006;60(12):1314-1323. PMID:
16806094.
53. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 2002;97(5580):353-356. PMID:
12130773.
54. Liu HL, Zhao G, Zhang H, Shi LD. Long-term treadmill exercise inhibits the progression of Alzheimer’s disease-like neuropathology in the hippocampus of APP/PS1 transgenic mice. Behavioural brain research 2013;1(256):261-272.
55. Sun L, Liu SY, Zhou XW, Wang XC, Liu R, Wang Q, Wang JZ. Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats. Neuroscience 2003;118(4):1175-82. PMID:
12732260.